Ningxia Qiyuan Pharmaceutical Co., Ltd.
Ningxia Qiyuan Pharma. is mainly focus on the manufacturing of Active Pharmaceutical Ingredients (API), Intermediates, Food & Feed additives, including Tetracycline Hydrochloride, Tetracycline Base, Erythromycin Base, Azithromycin, and Vitamins.
Catalog
Documents
-
Allergens
(visible)
Click to download A -
COA template
(visible)
Click to download COA -
Country of origin
(visible)
Click to download COO -
Item questionnaire
(visible)
Click to download IQ -
Nutrition
(visible)
Click to download N -
Product specification
(visible)
Click to download PS -
SDS (Safety Data Sheet)
(visible)
Click to download SDS -
Suitability requirements
(visible)
Click to download SR
Locations
| Location name | Address |
|---|---|
| Ningxia Qiyuan Pharmaceutical Co., Ltd. | No.1 Qiyuan Street, Wangyuan Industrial Area Yinchuan, Ningxia 750101 CHN |
Documents
| Type | Location | File name | Effective | Expiration |
|---|---|---|---|---|
| Allergen Control Policy | Ningxia Qiyuan Pharmaceutical Co., Ltd. | Allergen Control Policy of Ningxia Qiyuan-20240403.pdf | 4/3/2024 | 4/3/2026 |
| CA Transparency Act | Ningxia Qiyuan Pharmaceutical Co., Ltd. | CA Transparency Act for Ascorbic Acid-20230918.pdf | 9/18/2023 | 9/17/2025 |
| CTPAT | Ningxia Qiyuan Pharmaceutical Co., Ltd. | CTPAT Statement-Ningxia Qiyuan-20240605.pdf | 6/5/2024 | 6/5/2025 |
| Environmental Policy | Ningxia Qiyuan Pharmaceutical Co., Ltd. | Environmental Control Policy of Ningxia Qiyuan-2024.pdf | 6/5/2024 | 6/5/2025 |
| Ethical Code of Conduct | Ningxia Qiyuan Pharmaceutical Co., Ltd. | Ethical Souring Supplier Declaration Form-20230802.pdf | 8/2/2023 | 8/1/2025 |
| Bioterrorism Letter | Ningxia Qiyuan Pharmaceutical Co., Ltd. | FDA Bioterrorism (Registration) Statement-20240119.pdf | 1/19/2024 | 1/18/2025 |
| FDA Registration | Ningxia Qiyuan Pharmaceutical Co., Ltd. | FDA Bioterrorism Registration Statement-20250107.pdf | 1/7/2025 | 1/7/2027 |
| Foreign Material Control Statement | Ningxia Qiyuan Pharmaceutical Co., Ltd. | Foreign Material Control Statement for Ascorbic Acid-20230223.pdf | 2/23/2023 | 2/22/2026 |
| 3rd Party Audit Report | Ningxia Qiyuan Pharmaceutical Co., Ltd. | FSSC22000 Audit Report for Ningxia Qiyuan-2023.pdf | 9/26/2023 | 9/25/2026 |
| GFSI Audit Report | Ningxia Qiyuan Pharmaceutical Co., Ltd. | FSSC22000 Audit Report for Ningxia Qiyuan-2024.pdf | 7/8/2024 | 9/25/2026 |
| 3rd Party Audit Certificate | Ningxia Qiyuan Pharmaceutical Co., Ltd. | FSSC22000 Certificate-Ningxia Qiyuan-20230926.pdf | 9/26/2023 | 9/25/2026 |
| GFSI Certificate | Ningxia Qiyuan Pharmaceutical Co., Ltd. | FSSC22000 Certificate-Ningxia Qiyuan-20260925.pdf | 7/8/2024 | 9/25/2026 |
| Letter of Guarantee | Ningxia Qiyuan Pharmaceutical Co., Ltd. | Letter of Continuing Guarantee-20230213.pdf | 2/13/2023 | 2/12/2025 |
| HACCP Plan (Facility) | Ningxia Qiyuan Pharmaceutical Co., Ltd. | List of CCPs for Vitamin C-Ningxia Qiyuan-2023.pdf | 1/31/2023 | 1/30/2025 |
| Recall/Emergency/Contact List | Ningxia Qiyuan Pharmaceutical Co., Ltd. | List of Contacts for Product Recall Team-2025.pdf | 1/8/2025 | 1/8/2026 |
| 3rd Party Audit Corrective Action Plan | Ningxia Qiyuan Pharmaceutical Co., Ltd. | Ningxia Qiyuan_AFTAO 0231_C6V1_FSSC CAR-20230707.pdf | 8/24/2023 | 8/23/2026 |
| GFSI Corrective Action | Ningxia Qiyuan Pharmaceutical Co., Ltd. | Ningxia Qiyuan_AFTAO 0231_C6V1_FSSC CAR-20230707.pdf | 9/26/2023 | 9/25/2026 |
| Coronavirus | Ningxia Qiyuan Pharmaceutical Co., Ltd. | NotApplicable_Coronavirus.pdf | 2/26/2024 | 2/25/2027 |
| Recall Plan | Ningxia Qiyuan Pharmaceutical Co., Ltd. | SMP for Product Recall-QYSMP-ZB-B004-R10.pdf | 6/5/2024 | 6/5/2025 |
| Supplier Approval Program Statement | Ningxia Qiyuan Pharmaceutical Co., Ltd. | SMP for Supplier Qualification-2024.pdf | 6/5/2024 | 6/5/2025 |
| HARPC Food Safety Plan (Facility) | Ningxia Qiyuan Pharmaceutical Co., Ltd. | Statement about Food Defense and Food Safety-20240226.pdf | 2/26/2024 | 2/25/2027 |
| Food Defense Plan Statement | Ningxia Qiyuan Pharmaceutical Co., Ltd. | Statement about Food Defense and Food Safety-20250108.pdf | 1/8/2025 | 1/8/2027 |
| Supplier Questionnaire | Ningxia Qiyuan Pharmaceutical Co., Ltd. | Supplier Questionnaire.pdf | 1/8/2025 | 1/8/2027 |
| Sustainability (Level 1) | Ningxia Qiyuan Pharmaceutical Co., Ltd. | Sustainability (Level 1).pdf | 1/8/2025 | 1/8/2028 |
| Sustainability (Level 2) | Ningxia Qiyuan Pharmaceutical Co., Ltd. | Sustainability (Level 2).pdf | 1/8/2025 | 1/8/2028 |
| Vegan/Vegetarian Statement | Ningxia Qiyuan Pharmaceutical Co., Ltd. | Vegan Declaration for Ascorbic Acid-20230105.pdf | 1/5/2023 | 1/4/2025 |